New CIDP Clinical Trial: Nipocalimab for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
1:07
New CIDP Clinical Trial: Nipocalimab for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
519 viewsNov 30, 2022
YouTubePower Life Sciences
Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients
Nipocalimab pivotal Phase 3 trial demonstrates longest sustained disease control in FcRn class for broadest population of myasthenia gravis patients
Jun 28, 2024
nasdaq.com
Johnson & Johnson Unveils New Data Showing Nipocalimab Is the First and Only Investigational Fcrn Backer with Potential to Reduce Systemic Lupus Erythematosus Activity in A Phase 2 Study
Johnson & Johnson Unveils New Data Showing Nipocalimab Is the First and Only Investigational Fcrn Backer with Potential to Reduce Systemic Lupus Erythematosus Activity in A Phase 2 Study
4 months ago
marketscreener.com
Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD | NeurologyLive - Clinical Neurology News and Neurology Expert Insights
May 6, 2024
neurologylive.com
Do you want to understand more about CIDP? Watch this video that breaks down how CIDP works and other must-know topics. CIDP=chronic inflammatory demyelinating polyneuropathy. ©2024 argenx. All rights reserved. | Shining Through CIDP
0:16
Do you want to understand more about CIDP? Watch this video that breaks down how CIDP works and other must-know topics. CIDP=chronic inflammatory demyelinating polyneuropathy. ©2024 argenx. All rights reserved. | Shining Through CIDP
45.5K viewsJan 2, 2025
FacebookShining Through CIDP
Nipocalimab’s Promising Potential in Advancing gMG Care | AJMC
2:56
Nipocalimab’s Promising Potential in Advancing gMG Care | AJMC
Feb 11, 2025
ajmc.com
Phase 2b JASMINE trial of nipocalimab demonstrates positive results for treatment of systemic lupus erythematosus | Lupus Foundation of America https://www.lupus.org/news/phase-2b-jasmine-trial-of-nipocalimab-demonstrates-positive-results-for-treatment-of-systemic
0:13
Phase 2b JASMINE trial of nipocalimab demonstrates positive results for treatment of systemic lupus erythematosus | Lupus Foundation of America https://www.lupus.org/news/phase-2b-jasmine-trial-of-nipocalimab-demonstrates-positive-results-for-treatment-of-systemic
244 views3 months ago
TikTokcarsonkleppe
0:33
Discover 6 steps from the CIDP community that can help when reconsidering treatment. CIDP=chronic inflammatory demyelinating polyneuropathy. ©2026 argenx. All rights reserved. | Shining Through CIDP
56.2K views3 months ago
FacebookShining Through CIDP
Long-Term Management of CIDP with GAMUNEX®-C | Official Site for Patients
Jun 13, 2022
gamunex-c.com
0:23
Download a guide to track symptoms and abilities aimed to help have more productive conversations with doctors. CIDP=chronic inflammatory demyelinating polyneuropathy. ©2024 argenx. All rights reserved. | Shining Through CIDP
317.2K viewsApr 7, 2025
FacebookShining Through CIDP
52:39
Dazodalibep vs. Nipocalimab: Patient Perspectives on Sjogren's Clinical Trials
985 views8 months ago
YouTubeKara Wada MD | Allergy, MCAS & Sjogren’s
12:25
Self-administering for CIDP | HIZENTRA® Immune Globulin Subcutaneous (Human) 20% Liquid
Apr 30, 2025
hizentra.com
25:49
NVJC Ep. 58 Myasthenia Gravis/ALS/Neuromuscular: Safety & Efficacy of Nipocalimab in Patients w/ MG
518 viewsJul 1, 2024
YouTubeNeurology Journal
17:34
The Development of Nipocalimab for the Treatment of Sjögren’s Disease
323 views5 months ago
YouTubeCheckRare
22:21
Nipocalimab for Sjogren's: Clinical Trial Update (Side Effects, Eligibility & More)
1.8K viewsMay 7, 2025
YouTubeKara Wada MD | Allergy, MCAS & Sjogren’s
Kara Wada MD | Allergy, MCAS, & Sjogren’s Specialist on Instagram: "A new era of Sjogren's treatment? Nipocalimab is making waves – and I'm breaking down the science, eligibility, and side effects in my latest YouTube video. A few weeks ago, I shared the exciting news about Nipocalimab receiving FDA fast-track designation for Sjögren's. Many of you had questions, so in this video, we dive deep into how Nipocalimab actually works. We explore: ✅ The science behind FcRn antagonists (it's all about
2.7K views1 year ago
Instagramimmuneconfidentmd
3:42
Efficacy and Safety of Nipocalimab for Sjogren's Syndrome
950 viewsNov 18, 2024
YouTubeRheumNow
3:46
How Nipocalimab Works: A Targeted Attack on Autoantibodies in Myasthenia Gravis │ PHARMACOLOGY
632 views1 year ago
YouTubePharmacology Insights
5:03
Nipocalimab Granted Fast Track Designation in Systemic Lupus Erythematosus
61 views1 month ago
YouTubeCheckRare
2:41
How Nipocalimab works for Sjogren's
1.3K viewsMay 7, 2025
YouTubeKara Wada MD | Allergy, MCAS & Sjogren’s
2:39
The Potential of Nipocalimab as a Treatment for Autoantibody Mediated Diseases
989 viewsNov 8, 2023
YouTubeNeurologyLive
8:57
#CIDP, Variants and their treatment explained (including CIDP #MADSAM DADS #MMN)
45.2K viewsAug 21, 2016
YouTubeNeurophysiology
1:47:34
Managing Your CIDP (Sorting Out Your Diagnosis and Treatment)
71.9K viewsJun 17, 2015
YouTubegbscidp
25:20
Optimizing Outcomes in CIDP: Honing Diagnostic Accuracy, Personalizing Treatment Plans
39.3K viewsAug 3, 2022
YouTubePeerView CME
2:27
IMAAVY (nipocalimab-aahu) injection - generalized myasthenia gravis (gMG)
831 views11 months ago
YouTubePharmacy Talk USA
2:06
CIDP is often missed because it looks like other nerve disorders. But this is not just numbness or tingling. Progressive or relapsing weakness, especially in the hips and thighs, is a red flag. CIDP is an autoimmune attack on the nerves. And when it is recognized early, treatment can change lives. Not all nerve damage is permanent. Some of it is inflammatory. Some of it may be reversible. #AutoimmuneDisease #Neurology #LearnOnTikTok #TikTokLearningCampaign #medicaleducation
39.8K views3 months ago
TikTokdoctor.bing
9:52
Nipocalimab , a new FDA approved drug for myasthenia gravis patients
203 viewsMay 4, 2025
YouTubeflow with life
14:51
New Hope for Sjögren's Disease: Nipocalimab Receives FDA Fast Track Designation
3.4K viewsApr 16, 2025
YouTubeKara Wada MD | Allergy, MCAS & Sjogren’s
1:14
CIDP Clinical Criteria Explained | Neurology High-Yield 🧠
132 views6 months ago
YouTubeConceptual Medicine
32:49
Navigating the Patient Journey From CIDP Diagnosis to Initial Treatment and Long-Term Maintenance
22.9K viewsMar 1, 2018
YouTubePeerView CME
See more